Le Lézard
Classified in: Health
Subject: SVY

The global catheter market size is expected to reach USD 77.7 billion by 2026 registering a CAGR of 9.7%


NEW YORK, Aug. 20, 2019 /PRNewswire/ --


Read the full report: https://www.reportlinker.com/p05807285/?utm_source=PRN


The global catheter market size is expected to reach USD 77.7 billion by 2026 registering a CAGR of 9.7%. Increasing prevalence of chronic diseases and supportive insurance policies are some of the prime factors boosting the market growth. Presence of multi-national manufacturers and improving medical facilities, especially across developing regions, are also anticipated to propel the market growth over the forecast period.

As per the statistics published by the WHO, chronic diseases is anticipated to contribute to 73% of all deaths and 60% of the global burden of disease by 2020.The rise in geriatric population has also led to increase in number of hospitalizations and surgeries anticipating the market growth.

Catheters have undergone technological advancements; for instance, miniaturized products and introduction of antimicrobial catheters to reduce associated infections. Wide usage of minimally invasive surgeries is expected to favor the market growth.

Rising awareness about catheters has in turn boosted their demand.In addition, increasing number of midscale catheter manufacturers gaining a higher market share is expected to promote the market growth.

Furthermore, rise in funding by various government bodies and medical device manufacturers for R&D will boost the market growth. However, requirement of intensive capital for the development of advanced devices may obstruct market development.

Further key findings from the study suggest:
? The cardiovascular product segment led the market in 2018 owing to increase in the number of patients suffering from chronic Cardiovascular Diseases (CVDs)
? Specialty catheters is expected to be the fastest-growing product segment over the forecast period due to rising prevalence of target diseases and demand for minimally invasive procedures
? Asia Pacific is anticipated to witness the fastest CAGR from 2019 to 2026 owing to rising cases of kidney and cardiovascular diseases, improving medical facilities, and supportive insurance policies
? Some of the key companies in the global catheter market are Medtronic Plc.; Convatec Corp.; Smiths Medical, Inc.; Boston Scientific Corp.; and Coloplast A/S
? The market is price-sensitive with many small-, medium-, and large-scale companies. Key companies focus on product bundling strategies
? Strategic partnerships between the manufacturers and the healthcare establishments intensify the market competition

Read the full report: https://www.reportlinker.com/p05807285/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...



News published on and distributed by: